Nanoparticles for Diagnosis and Target Therapy in Pediatric Brain Cancers

Pediatric brain tumors represent the most common types of childhood cancer and novel diagnostic and therapeutic solutions are urgently needed. The gold standard treatment option for brain cancers in children, as in adults, is tumor resection followed by radio- and chemotherapy, but with discouraging...

Full description

Saved in:
Bibliographic Details
Published in:Diagnostics (Basel) 2022-01, Vol.12 (1), p.173
Main Authors: Guido, Clara, Baldari, Clara, Maiorano, Gabriele, Mastronuzzi, Angela, Carai, Andrea, Quintarelli, Concetta, De Angelis, Biagio, Cortese, Barbara, Gigli, Giuseppe, Palamà, Ilaria Elena
Format: Article
Language:English
Subjects:
blood–brain barrier
Brain cancer
Cancer therapies
Chemotherapy
Clinical trials
Contrast agents
Drugs
Magnetic resonance imaging
Medical prognosis
nanocarriers
Nanoparticles
Nanotechnology
Nervous system
pediatric brain cancers
Pediatrics
Peptides
Polyethylene glycol
Quantum dots
Radiation therapy
Review
Tumors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c499t-362c9d3f129a9096460e0acce9174056aeaaef4db7319ef6216e521ae1bbe5933
cites cdi_FETCH-LOGICAL-c499t-362c9d3f129a9096460e0acce9174056aeaaef4db7319ef6216e521ae1bbe5933
container_end_page
container_issue 1
container_start_page 173
container_title Diagnostics (Basel)
container_volume 12
creator Guido, Clara
Baldari, Clara
Maiorano, Gabriele
Mastronuzzi, Angela
Carai, Andrea
Quintarelli, Concetta
De Angelis, Biagio
Cortese, Barbara
Gigli, Giuseppe
Palamà, Ilaria Elena
description Pediatric brain tumors represent the most common types of childhood cancer and novel diagnostic and therapeutic solutions are urgently needed. The gold standard treatment option for brain cancers in children, as in adults, is tumor resection followed by radio- and chemotherapy, but with discouraging therapeutic results. In particular, the last two treatments are often associated to significant neurotoxicity in the developing brain of a child, with resulting disabilities such as cognitive problems, neuroendocrine, and neurosensory dysfunctions/deficits. Nanoparticles have been increasingly and thoroughly investigated as they show great promises as diagnostic tools and vectors for gene/drug therapy for pediatric brain cancer due to their ability to cross the blood-brain barrier. In this review we will discuss the developments of nanoparticle-based strategies as novel precision nanomedicine tools for diagnosis and therapy in pediatric brain cancers, with a particular focus on targeting strategies to overcome the main physiological obstacles that are represented by blood-brain barrier.
doi_str_mv 10.3390/diagnostics12010173
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_58296deb21cf4a11aa3a23699f595612</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_58296deb21cf4a11aa3a23699f595612</doaj_id><sourcerecordid>2621281641</sourcerecordid><originalsourceid>FETCH-LOGICAL-c499t-362c9d3f129a9096460e0acce9174056aeaaef4db7319ef6216e521ae1bbe5933</originalsourceid><addsrcrecordid>eNptkUtvEzEUhS0EolXpL0BCI7FhE_D1a8YbJAivSBWwCGvrjudO6mhiB3uC1H-PS0LVIryxr33uZx8fxp4Dfy2l5W-GgJuYyhx8AcGBQysfsXPBW71QCrrH99Zn7LKULa_DguyEfsrOpOZaScXP2eorxrTHXEETlWZMuflwRIfSYByaNeYNzc36mjLub5oQm-9UL59z8M37jLVeYvSUyzP2ZMSp0OVpvmA_Pn1cL78srr59Xi3fXS28snZeSCO8HeQIwqLl1ijDiaP3ZKFVXBskRBrV0LcSLI1GgCEtAAn6nrSV8oKtjtwh4dbtc9hhvnEJg_uzkfLGnew43QlrBuoF-FEhAKJEIY21o7bagKist0fW_tDvaPAU54zTA-jDkxiu3Sb9cl3bKstVBbw6AXL6eaAyu10onqYJI6VDccIIIaovrqv05T_SbTrkWL_qVgWiA6OgquRR5XMqJdN49xjg7jZ595_ka9eL-z7uev7mLH8Dccirww</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2621281641</pqid></control><display><type>article</type><title>Nanoparticles for Diagnosis and Target Therapy in Pediatric Brain Cancers</title><source>Publicly Available Content (ProQuest)</source><source>PubMed Central</source><creator>Guido, Clara ; Baldari, Clara ; Maiorano, Gabriele ; Mastronuzzi, Angela ; Carai, Andrea ; Quintarelli, Concetta ; De Angelis, Biagio ; Cortese, Barbara ; Gigli, Giuseppe ; Palamà, Ilaria Elena</creator><creatorcontrib>Guido, Clara ; Baldari, Clara ; Maiorano, Gabriele ; Mastronuzzi, Angela ; Carai, Andrea ; Quintarelli, Concetta ; De Angelis, Biagio ; Cortese, Barbara ; Gigli, Giuseppe ; Palamà, Ilaria Elena</creatorcontrib><description>Pediatric brain tumors represent the most common types of childhood cancer and novel diagnostic and therapeutic solutions are urgently needed. The gold standard treatment option for brain cancers in children, as in adults, is tumor resection followed by radio- and chemotherapy, but with discouraging therapeutic results. In particular, the last two treatments are often associated to significant neurotoxicity in the developing brain of a child, with resulting disabilities such as cognitive problems, neuroendocrine, and neurosensory dysfunctions/deficits. Nanoparticles have been increasingly and thoroughly investigated as they show great promises as diagnostic tools and vectors for gene/drug therapy for pediatric brain cancer due to their ability to cross the blood-brain barrier. In this review we will discuss the developments of nanoparticle-based strategies as novel precision nanomedicine tools for diagnosis and therapy in pediatric brain cancers, with a particular focus on targeting strategies to overcome the main physiological obstacles that are represented by blood-brain barrier.</description><identifier>ISSN: 2075-4418</identifier><identifier>EISSN: 2075-4418</identifier><identifier>DOI: 10.3390/diagnostics12010173</identifier><identifier>PMID: 35054340</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>blood–brain barrier ; Brain cancer ; Cancer therapies ; Chemotherapy ; Clinical trials ; Contrast agents ; Drugs ; Magnetic resonance imaging ; Medical prognosis ; nanocarriers ; Nanoparticles ; Nanotechnology ; Nervous system ; pediatric brain cancers ; Pediatrics ; Peptides ; Polyethylene glycol ; Quantum dots ; Radiation therapy ; Review ; Tumors</subject><ispartof>Diagnostics (Basel), 2022-01, Vol.12 (1), p.173</ispartof><rights>2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2022 by the authors. 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c499t-362c9d3f129a9096460e0acce9174056aeaaef4db7319ef6216e521ae1bbe5933</citedby><cites>FETCH-LOGICAL-c499t-362c9d3f129a9096460e0acce9174056aeaaef4db7319ef6216e521ae1bbe5933</cites><orcidid>0000-0002-4408-2373 ; 0000-0002-5203-7855 ; 0000-0001-8667-7255 ; 0000-0003-2205-2293 ; 0000-0002-7938-737X ; 0000-0003-4420-0680</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2621281641/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2621281641?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35054340$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Guido, Clara</creatorcontrib><creatorcontrib>Baldari, Clara</creatorcontrib><creatorcontrib>Maiorano, Gabriele</creatorcontrib><creatorcontrib>Mastronuzzi, Angela</creatorcontrib><creatorcontrib>Carai, Andrea</creatorcontrib><creatorcontrib>Quintarelli, Concetta</creatorcontrib><creatorcontrib>De Angelis, Biagio</creatorcontrib><creatorcontrib>Cortese, Barbara</creatorcontrib><creatorcontrib>Gigli, Giuseppe</creatorcontrib><creatorcontrib>Palamà, Ilaria Elena</creatorcontrib><title>Nanoparticles for Diagnosis and Target Therapy in Pediatric Brain Cancers</title><title>Diagnostics (Basel)</title><addtitle>Diagnostics (Basel)</addtitle><description>Pediatric brain tumors represent the most common types of childhood cancer and novel diagnostic and therapeutic solutions are urgently needed. The gold standard treatment option for brain cancers in children, as in adults, is tumor resection followed by radio- and chemotherapy, but with discouraging therapeutic results. In particular, the last two treatments are often associated to significant neurotoxicity in the developing brain of a child, with resulting disabilities such as cognitive problems, neuroendocrine, and neurosensory dysfunctions/deficits. Nanoparticles have been increasingly and thoroughly investigated as they show great promises as diagnostic tools and vectors for gene/drug therapy for pediatric brain cancer due to their ability to cross the blood-brain barrier. In this review we will discuss the developments of nanoparticle-based strategies as novel precision nanomedicine tools for diagnosis and therapy in pediatric brain cancers, with a particular focus on targeting strategies to overcome the main physiological obstacles that are represented by blood-brain barrier.</description><subject>blood–brain barrier</subject><subject>Brain cancer</subject><subject>Cancer therapies</subject><subject>Chemotherapy</subject><subject>Clinical trials</subject><subject>Contrast agents</subject><subject>Drugs</subject><subject>Magnetic resonance imaging</subject><subject>Medical prognosis</subject><subject>nanocarriers</subject><subject>Nanoparticles</subject><subject>Nanotechnology</subject><subject>Nervous system</subject><subject>pediatric brain cancers</subject><subject>Pediatrics</subject><subject>Peptides</subject><subject>Polyethylene glycol</subject><subject>Quantum dots</subject><subject>Radiation therapy</subject><subject>Review</subject><subject>Tumors</subject><issn>2075-4418</issn><issn>2075-4418</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptkUtvEzEUhS0EolXpL0BCI7FhE_D1a8YbJAivSBWwCGvrjudO6mhiB3uC1H-PS0LVIryxr33uZx8fxp4Dfy2l5W-GgJuYyhx8AcGBQysfsXPBW71QCrrH99Zn7LKULa_DguyEfsrOpOZaScXP2eorxrTHXEETlWZMuflwRIfSYByaNeYNzc36mjLub5oQm-9UL59z8M37jLVeYvSUyzP2ZMSp0OVpvmA_Pn1cL78srr59Xi3fXS28snZeSCO8HeQIwqLl1ijDiaP3ZKFVXBskRBrV0LcSLI1GgCEtAAn6nrSV8oKtjtwh4dbtc9hhvnEJg_uzkfLGnew43QlrBuoF-FEhAKJEIY21o7bagKist0fW_tDvaPAU54zTA-jDkxiu3Sb9cl3bKstVBbw6AXL6eaAyu10onqYJI6VDccIIIaovrqv05T_SbTrkWL_qVgWiA6OgquRR5XMqJdN49xjg7jZ595_ka9eL-z7uev7mLH8Dccirww</recordid><startdate>20220112</startdate><enddate>20220112</enddate><creator>Guido, Clara</creator><creator>Baldari, Clara</creator><creator>Maiorano, Gabriele</creator><creator>Mastronuzzi, Angela</creator><creator>Carai, Andrea</creator><creator>Quintarelli, Concetta</creator><creator>De Angelis, Biagio</creator><creator>Cortese, Barbara</creator><creator>Gigli, Giuseppe</creator><creator>Palamà, Ilaria Elena</creator><general>MDPI AG</general><general>MDPI</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7XB</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-4408-2373</orcidid><orcidid>https://orcid.org/0000-0002-5203-7855</orcidid><orcidid>https://orcid.org/0000-0001-8667-7255</orcidid><orcidid>https://orcid.org/0000-0003-2205-2293</orcidid><orcidid>https://orcid.org/0000-0002-7938-737X</orcidid><orcidid>https://orcid.org/0000-0003-4420-0680</orcidid></search><sort><creationdate>20220112</creationdate><title>Nanoparticles for Diagnosis and Target Therapy in Pediatric Brain Cancers</title><author>Guido, Clara ; Baldari, Clara ; Maiorano, Gabriele ; Mastronuzzi, Angela ; Carai, Andrea ; Quintarelli, Concetta ; De Angelis, Biagio ; Cortese, Barbara ; Gigli, Giuseppe ; Palamà, Ilaria Elena</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c499t-362c9d3f129a9096460e0acce9174056aeaaef4db7319ef6216e521ae1bbe5933</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>blood–brain barrier</topic><topic>Brain cancer</topic><topic>Cancer therapies</topic><topic>Chemotherapy</topic><topic>Clinical trials</topic><topic>Contrast agents</topic><topic>Drugs</topic><topic>Magnetic resonance imaging</topic><topic>Medical prognosis</topic><topic>nanocarriers</topic><topic>Nanoparticles</topic><topic>Nanotechnology</topic><topic>Nervous system</topic><topic>pediatric brain cancers</topic><topic>Pediatrics</topic><topic>Peptides</topic><topic>Polyethylene glycol</topic><topic>Quantum dots</topic><topic>Radiation therapy</topic><topic>Review</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Guido, Clara</creatorcontrib><creatorcontrib>Baldari, Clara</creatorcontrib><creatorcontrib>Maiorano, Gabriele</creatorcontrib><creatorcontrib>Mastronuzzi, Angela</creatorcontrib><creatorcontrib>Carai, Andrea</creatorcontrib><creatorcontrib>Quintarelli, Concetta</creatorcontrib><creatorcontrib>De Angelis, Biagio</creatorcontrib><creatorcontrib>Cortese, Barbara</creatorcontrib><creatorcontrib>Gigli, Giuseppe</creatorcontrib><creatorcontrib>Palamà, Ilaria Elena</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest_Research Library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Diagnostics (Basel)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Guido, Clara</au><au>Baldari, Clara</au><au>Maiorano, Gabriele</au><au>Mastronuzzi, Angela</au><au>Carai, Andrea</au><au>Quintarelli, Concetta</au><au>De Angelis, Biagio</au><au>Cortese, Barbara</au><au>Gigli, Giuseppe</au><au>Palamà, Ilaria Elena</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Nanoparticles for Diagnosis and Target Therapy in Pediatric Brain Cancers</atitle><jtitle>Diagnostics (Basel)</jtitle><addtitle>Diagnostics (Basel)</addtitle><date>2022-01-12</date><risdate>2022</risdate><volume>12</volume><issue>1</issue><spage>173</spage><pages>173-</pages><issn>2075-4418</issn><eissn>2075-4418</eissn><abstract>Pediatric brain tumors represent the most common types of childhood cancer and novel diagnostic and therapeutic solutions are urgently needed. The gold standard treatment option for brain cancers in children, as in adults, is tumor resection followed by radio- and chemotherapy, but with discouraging therapeutic results. In particular, the last two treatments are often associated to significant neurotoxicity in the developing brain of a child, with resulting disabilities such as cognitive problems, neuroendocrine, and neurosensory dysfunctions/deficits. Nanoparticles have been increasingly and thoroughly investigated as they show great promises as diagnostic tools and vectors for gene/drug therapy for pediatric brain cancer due to their ability to cross the blood-brain barrier. In this review we will discuss the developments of nanoparticle-based strategies as novel precision nanomedicine tools for diagnosis and therapy in pediatric brain cancers, with a particular focus on targeting strategies to overcome the main physiological obstacles that are represented by blood-brain barrier.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>35054340</pmid><doi>10.3390/diagnostics12010173</doi><orcidid>https://orcid.org/0000-0002-4408-2373</orcidid><orcidid>https://orcid.org/0000-0002-5203-7855</orcidid><orcidid>https://orcid.org/0000-0001-8667-7255</orcidid><orcidid>https://orcid.org/0000-0003-2205-2293</orcidid><orcidid>https://orcid.org/0000-0002-7938-737X</orcidid><orcidid>https://orcid.org/0000-0003-4420-0680</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2075-4418
ispartof Diagnostics (Basel), 2022-01, Vol.12 (1), p.173
issn 2075-4418
2075-4418
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_58296deb21cf4a11aa3a23699f595612
source Publicly Available Content (ProQuest); PubMed Central
subjects blood–brain barrier
Brain cancer
Cancer therapies
Chemotherapy
Clinical trials
Contrast agents
Drugs
Magnetic resonance imaging
Medical prognosis
nanocarriers
Nanoparticles
Nanotechnology
Nervous system
pediatric brain cancers
Pediatrics
Peptides
Polyethylene glycol
Quantum dots
Radiation therapy
Review
Tumors
title Nanoparticles for Diagnosis and Target Therapy in Pediatric Brain Cancers
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-30T23%3A35%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Nanoparticles%20for%20Diagnosis%20and%20Target%20Therapy%20in%20Pediatric%20Brain%20Cancers&rft.jtitle=Diagnostics%20(Basel)&rft.au=Guido,%20Clara&rft.date=2022-01-12&rft.volume=12&rft.issue=1&rft.spage=173&rft.pages=173-&rft.issn=2075-4418&rft.eissn=2075-4418&rft_id=info:doi/10.3390/diagnostics12010173&rft_dat=%3Cproquest_doaj_%3E2621281641%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c499t-362c9d3f129a9096460e0acce9174056aeaaef4db7319ef6216e521ae1bbe5933%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2621281641&rft_id=info:pmid/35054340&rfr_iscdi=true